[Ivabradine in the treatment of patients with angina pectoris: lessons of the BEAUTIFUL trial].
The article is devoted to results of additional analysis of a randomized, double-blind, placebo-controlled, parallel-group BEAUTIFUL trial. Effects of If inhibitor ivabradine in patients with ischemic heart disease, left ventricular dysfunction and stable angina were analyzed.